HMPL-306
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for HMPL-306, covering 2025-07-31 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study of HMPL-306 in Advanced Solid Tumors With IDH Mutations [Phase 1]